Need to Know: Why Coke, others, may be spared, as a $100 billion opportunity in weight loss drugs unfolds says JPMorgan
JPMorgan says the weight-loss drug industry is now a “$100 billion plus opportunity.” Coke is one of the stocks they say is likely to get hit less hard.
